Key facts
- Eden (Healthcare Technology Systems)’s last known valuation is $1.7M (Aug 2018).
- It has raised $48.7M; the latest was Later Stage VC ($22.0M) in Oct 2025.
- Notable investors include Y Combinator, Alumni Ventures, MassChallenge, Soma Capital, Khosla Ventures — 39 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 39 names
- ·Watchlist + deal alerts for Eden (Healthcare Technology Systems)
- ·The full record, as it builds
Funding rounds
No funding rounds for Eden (Healthcare Technology Systems) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Eden (Healthcare Technology Systems)
Developer of non-invasive breast health technology designed to democratize access to early breast cancer risk assessment. The company's wearable device is equipped with tactile sensors that are designed to map the surface of the breast and surrounding areas, enabling women to keep track of the changes in breast temperature, size, and weight with the help of biosensors inside the cup, which constantly monitor information.
- Sector
- Healthcare
- HQ
- Mexico City, Mexico
- Founded
- 2016
- Employees
- 338
- Website
- edenmed.com/
- Ownership
- Privately Held (backing)
Eden (Healthcare Technology Systems) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Eden (Healthcare Technology Systems) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Eden (Healthcare Technology Systems) in its N-PORT filings yet. We sweep new filings monthly.